22 results found.

Glomerulonephritis, Lupus Nephritis, Membranous Glomerulonephriti Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 5 years or older.
- Studies of Immunologically-Mediated Kidney Diseases.

Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Clinical Trial using Teplizumab

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Recruiting 8 years to 45 years.
- AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus.
Teplizumab

Heart Transplantation, Kidney Transplantation, Liver Transplantat Clinical Trial

Genentech - Recruiting N/A or older.
- The Mycophenolate Pregnancy Registry.

Biliary Atresia Clinical Trial

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Recruiting 1 year to 75 years.
- Biliary Atresia Study in Infants and Children (BASIC).

Moderate to Severe Secondary Hyperparathyroidism, or Stage 5 Chro Clinical Trial using Paricalcitol

AbbVie - Recruiting 18 years or older.
- A Prospective Open Label Pilot Clinical Study Evaluating the Efficacy of Paricalcitol on Erythropoietin Consumption in Calcitriol-resistant Patients.
Paricalcitol

Kidney Transplant Clinical Trial using Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal; MMF/Tacrolimus/Prednisone

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years or older.
- Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation.
Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal; MMF/Tacrolimus/Prednisone

Chronic Kidney Disease, Chronic Kidney Insufficiency, Chronic Ren Clinical Trial using Facilitated Clinical Decision Support; Clinical Decision Support Only

American Academy of Family Physicians - Recruiting 18 years or older.
- Improving Evidence-Based Primary Care for Chronic Kidney Disease.
Facilitated Clinical Decision Support; Clinical Decision Support Only

Anaemia Clinical Trial using GSK1278863; rhEPO

GlaxoSmithKline - Recruiting 18 years or older.
- A 24-week, Phase IIB, Randomized, Active-controlled, Parallel Group, Multi-center Study to Evaluate the Safety and Efficacy of GSK1278863 in Subjects With Anemia Associated With Chronic Kidney Diseases Who Are Not on Dialysis..
GSK1278863; rhEPO

Renal Impairment, Renal Insufficiency, Kidney Disease, or Kidney Clinical Trial using IDN-6556

Conatus Pharmaceuticals Inc. - Recruiting 18 years to 75 years.
- An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Severe Renal Impairment and in Matched Healthy Volunteers.
IDN-6556

Renal Impairment, Kidney Diseases, Urologic Diseases, Cancer, Hyp Clinical Trial using Renal hypothermia

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- A Randomized Controlled Trial of Renal Hypothermia During Partial Nephrectomy.
Renal hypothermia

Abnormal Glucose Tolerance, or Type 1 Diabetes Clinical Trial using CTLA4-Ig (Abatacept); Placebo

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Recruiting 6 years to 45 years.
- CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes.
CTLA4-Ig (Abatacept); Placebo

Kidney Diseases, or Glomerulosclerosis, Focal Clinical Trial using Kidney needle biopsy; DEXA Scan; X-rays; Retinoids for Podocyte Disease

National Institutes of Health Clinical Center (CC) - Recruiting 16 years or older.
- Retinoids for Podocyte Disease.
Kidney needle biopsy; DEXA Scan; X-rays; Retinoids for Podocyte Disease

Chronic Kidney Diseases, or Chronic Kidney Insufficiency Clinical Trial using general management; self-management; peer-assisted management

China Medical University Hospital - Recruiting 20 years to 85 years.
- The Cost Effectiveness and Evaluation of Disease Management of Chronic Kidney Disease and High Risk Population.
general management; self-management; peer-assisted management

Kidney Transplantation Clinical Trial using Antithymocyte globulin (ATG); Fludarabine; Low dose Pre-transplant cyclophosphamide; Total Body Irradiation; Acetaminophen; Diphenhydramine; Methylprednisolone; Bone Marrow; MESNA; Mycophenolate mofetil (MMF); Prednisone; Filgrastim; High dose post-transplant cyclophosphamide

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 65 years.
- Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (ITN054ST).
Antithymocyte globulin (ATG); Fludarabine; Low dose Pre-transplant cyclophosphamide; Total Body Irradiation; Acetaminophen; Diphenhydramine; Methylprednisolone; Bone Marrow; MESNA; Mycophenolate mofetil (MMF); Prednisone; Filgrastim; High dose post-transplant cyclophosphamide

Kidney Diseases Clinical Trial using High/ Low Phosphate diet

University of British Columbia - Recruiting 19 years or older.
- Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease.
High/ Low Phosphate diet

Aortic Aneurysm, Abdominal, Aortic Diseases, or Acute Kidney Inju Clinical Trial

Sygehus Lillebaelt - Recruiting 18 years or older.
- Haemodynamic Response to Aortic Surgery.

Kidney Diseases, Heart Diseases, or Diabetes Mellitus Clinical Trial using The Combined Cardiac Kidney Diabetes Care Clinic

University of British Columbia - Recruiting 18 years to 85 years.
- Randomized Controlled Trial Comparing Current Care in Multiple Clinics Vs Care in a Novel Cardiac, Diabetes & Kidney Care Clinic.
The Combined Cardiac Kidney Diabetes Care Clinic

Obesity and Type 2 Diabetes Clinical Trial using Circuit Training; Circuit training + motivational interviewing; Control

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Recruiting 14 years to 18 years.
- Circuit Training and Motivational Interviewing to Reduce Type 2 Diabetes in Youth.
Circuit Training; Circuit training + motivational interviewing; Control

Renal Insufficiency, Kidney Diseases, or Urologic Diseases Clinical Trial using Mirodenafil

Asan Medical Center - Recruiting 19 years to 64 years.
- Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients.
Mirodenafil

Chronic Disease, Kidney Diseases, or Cardiovascular Diseases Clinical Trial using rosiglitazone

Hospital Authority, Hong Kong - Recruiting 20 years to 75 years.
- Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?.
rosiglitazone

Kidney Diseases Clinical Trial using everolimus and tacrolimus

Hospital Universitario Ramon y Cajal - Recruiting 18 years to 65 years.
- A Pilot Study to Investigate Pharmacokinetic Characteristics of Everolimus in Patients Treated With Tacrolimus-Based Immunosuppression in De Novo Kidney Transplantation.
everolimus and tacrolimus